A Study of Circulating Exosome Proteomics In Gallbladder Carcinoma Patients
Sponsor: First Affiliated Hospital of Xinjiang Medical University
Listed as NCT03581435, this observational or N/A phase trial focuses on Gallbladder Carcinoma and Proteinosis and remains ongoing. Sponsored by First Affiliated Hospital of Xinjiang Medical University, it has been updated 11 times since 2018, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Change History
11 versions recorded-
Jun 2025 — Present [monthly]
Unknown
-
Mar 2025 — Jun 2025 [monthly]
Unknown
-
Sep 2024 — Mar 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
▶ Show 6 earlier versions
-
Oct 2021 — Dec 2021 [monthly]
Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Aug 2020 — Nov 2020 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2019 — Aug 2020 [monthly]
Recruiting
-
Aug 2018 — Jan 2019 [monthly]
Recruiting
First recorded
Jan 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- First Affiliated Hospital of Xinjiang Medical University
- Jining Medical University
- Second Affiliated Hospital of Nanchang University
- Shanghai Zhongshan Hosiptal
- The Affiliated Hospital of Inner Mongolia Medical University
- The Affiliated Hospital of Tianjin Medical University
- The First Affiliated Hospital of Bengbu Medical University
- The First Affiliated Hospital of Shanxi Medical University
- The First Hospital of Jilin University
- The first affiliated hospital of Zhongshan university
- liu yingbin
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Shanghai, China